Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Nejm-Cirrhosis'

Nejm-Cirrhosis published presentations and documents on DocSlides.

Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology
Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology
by badra
Duke University School of Medicine. Durham, North ...
MM: HCV and Cirrhosis Patient Case
MM: HCV and Cirrhosis Patient Case
by devin732
Chris Kolkman. PrimaryOne. Health. Meet MM. Patie...
Liver Cirrhosis GNT block
Liver Cirrhosis GNT block
by elise
Dec 2019. Liver cirrhosis. Objectives: . Define Ci...
Management of Cirrhosis for the Primary Care Provider
Management of Cirrhosis for the Primary Care Provider
by norah
Nicholas Lim, MD. Associate Professor of Medicine....
Management of cirrhosis Dr
Management of cirrhosis Dr
by eliza
Nowlan Selvapatt. Consultant Hepatologist. Imperia...
LIVER CIRRHOSIS – AYURVEDIC
LIVER CIRRHOSIS – AYURVEDIC
by paisley
TREATMENT . Dr. . Vikram. . Chauhan. is One of ...
HBV related cirrhosis Geoff Dusheiko
HBV related cirrhosis Geoff Dusheiko
by maxasp
Kings College Hospital London UK. . 20–50%. . ...
Decompensated cirrhosis Clinical Practice Guidelines
Decompensated cirrhosis Clinical Practice Guidelines
by kittie-lecroy
About these slides. These slides give a comprehen...
Cirrhosis and complications
Cirrhosis and complications
by conchita-marotz
Best of ILC 2018. About these slides. These slide...
Liver Cirrhosis
Liver Cirrhosis
by giovanna-bartolotta
KNH 411. Morgan . Deihs. Lydia Dysart. Objectives...
LIVER CIRRHOSIS –
LIVER CIRRHOSIS –
by danika-pritchard
AYURVEDIC . TREATMENT . Dr. . Vikram. . Chauhan....
Cirrhosis of the Liver
Cirrhosis of the Liver
by phoebe-click
Kelsey Conrad. Annelise. . Chmelik. September 24...
Can PCI for Stable CAD Prevent
Can PCI for Stable CAD Prevent
by gatlin
Spontaneous MI. ?. . Kirk N. Garratt MSc MD. John...
Selecting Direct Oral Anticoagulants and Reversal Agents
Selecting Direct Oral Anticoagulants and Reversal Agents
by tremblay
Geno J . Merli. , MD, MACP, FSVM, FHM. Professor M...
Dr . N. Kumarasamy Chief & Director
Dr . N. Kumarasamy Chief & Director
by bency
VHS- Infectious Diseases Medical Centre. Director/...
REVEAL: Randomized Evaluation of the Effects of
REVEAL: Randomized Evaluation of the Effects of
by stella
Anacetrapib. through Lipid Modification. First ti...
Anticoagulation for VTE: How Long?
Anticoagulation for VTE: How Long?
by sophie
Geoffrey Barnes, MD, MSc. University of Michigan. ...
Outpatient Care Update Illinois ACP
Outpatient Care Update Illinois ACP
by donetrand
November, 2017. Everyone’s Talking About. Mariju...
ISAR-REACT 5, comment
ISAR-REACT 5, comment
by trish-goza
ISAR-REACT 5, comment G. Montalescot Institute o...
SOMC 220 Small Literature Groups
SOMC 220 Small Literature Groups
by alexa-scheidler
Analyzing and Explaining Medical Research. Class ...
ICU lecture #2
ICU lecture #2
by tatiana-dople
Procedures:. Indications, Contraindications and t...
ACCP Cardiology PRN Journal Club
ACCP Cardiology PRN Journal Club
by tatiana-dople
Announcements . Thank you attending the ACCP Card...
Chronic Kidney Disease
Chronic Kidney Disease
by ellena-manuel
Baz. Lazar . Overview . Introduction. Discussion...
Patologia
Patologia
by mitsue-stanley
. Pneumococcica. . dell’adulto. :. . nuovi. ...
ACCP Cardiology PRN Journal Club
ACCP Cardiology PRN Journal Club
by karlyn-bohler
Announcements . Thank you attending the ACCP Card...
Therapies under investigation for COVID-19 and potential hepatotoxicity
Therapies under investigation for COVID-19 and potential hepatotoxicity
by thomas
Gamal. . Esmat. (Egypt). Treatment consideration...
Cholestasis and Cirrhosis
Cholestasis and Cirrhosis
by jasiah993
Khairat. . Battah,. . MD. Lecturer/. . consulta...
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
by hezekiah
FALDAPREVIR (BI 201335) + BI 207127 ± RIBAVIRIN. ...
NOTES: Rates for 15 –
NOTES: Rates for 15 –
by abigail
24 . for most years are unreliable due to small si...
Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy
Newly Approved Hepatitis C Virus Drugs: Approach to Initial Therapy
by della
Kristen M. Marks, MD. Assistant Professor. Weill C...
Insight into the history
Insight into the history
by elizabeth
of hepatitis C virus (HCV. ) infection; . a cohort...
Translational Liver Consortia:
Translational Liver Consortia:
by susan2
TLC and THCCC. Hashem B. El-Serag, MD, MPH. Chair ...
Liver issues for the Rhuematologist
Liver issues for the Rhuematologist
by cappi
David Wong, MD. University of Toronto. www.toronto...
PRIMARY BILIARY CIRRHOSIS
PRIMARY BILIARY CIRRHOSIS
by faith
PRESENTED BY : . Hawa-A-Elbarghthi. Marwa-A- . Elf...
effusions
effusions
by trinity
leural occur in 5% to 10% of patients with cirrhos...
THEACHIEVEMENTOFDOMINICJOHNCORRIGANbyRALAGNEWATaneveningmeetingofth
THEACHIEVEMENTOFDOMINICJOHNCORRIGANbyRALAGNEWATaneveningmeetingofth
by nicole
KWWSVGRLRUJ6...
FROM CIRRHOSIS TO PARAPARESIS
FROM CIRRHOSIS TO PARAPARESIS
by morton
211 Corresponding author: PORTAbbreviationsCRP ...
archiv euromedica 31303130 29ol 2830 num
archiv euromedica 31303130 29ol 2830 num
by wilson
| archiv euromedica  ol...
PTS phase 2a - LIVER Annette
PTS phase 2a - LIVER Annette
by BlueEyedBeauty
chanzu. and Shreya agrawal. The peer teaching soc...
COMPLICATIONS OF LIVER CIRRHOSIS
COMPLICATIONS OF LIVER CIRRHOSIS
by elyana
DR. SANJANA BHAGWAT. MODERATOR : DR. SHIMPA SHARMA...